Document is current
Any future updates will be listed below
-
Authors
Somnet, Kanpitcha
Wanram, Surasak
Chairam, Sanoe
Jarujamrus, Purim
Nacapricha, Duangjai
Lieberzeit, Peter A.
Amatatongchai, Maliwan
-
Funding
Funding for this research was provided by:
National Research Council of Thailand (N11A650144, N11A650144, N11A650144)
ASEA-UNINET (2023-2024/Uni Wein/10, 2023-2024/Uni Wein/10, 2023-2024/Uni Wein/10)
Fundamental Funds (FF) of the fiscal year 2567
Center of Excellence for Innovation in Chemistry (PERCH-CIC),
- License Information
-
More Information
Article History
Received: 17 November 2024
Accepted: 10 January 2025
First Online: 29 January 2025
Declarations
:
: The research was conducted in accordance with the Declaration of Helsinki and approved by the Human Research Ethics Committee of Ubon Ratchathani University. The committee confirmed that the proposed study aligns with international ethical standards, as well as with applicable laws, regulations, and national requirements. The research was approved under certification number UBU-REC-20/2567. Serum samples from cancer patients, with histopathologically confirmed diagnoses, were obtained with permission from the Ethical Committee of Ubon Ratchathani Cancer Hospital, Thailand (No. EC-10/2024).
: Informed consent was obtained from all individual participants included in the study. All participants were fully informed about the nature of the research and voluntarily agreed to participate.
: The authors declare no competing interests.
